Skip to content


  • Oral presentation
  • Open Access

Control of LTR transcription by SWI/SNF BAF and PBAF complexes

Retrovirology201411 (Suppl 1) :O47

  • Published:


  • Transcription Start Site
  • Chromatin Structure
  • Chromatin Remodel
  • Cellular Gene
  • Chromatin Remodel Complex

The transcription of HTLV-1 LTR is a highly regulated process by the organized chromatin structure within a cell's nucleus; chromatin is folded into compact fibers (30-400 nm thick), which physically prevents the accessibility of cellular promoters by transcriptional machinery. A variety of enzymes and protein complexes are present in the cell to mediate the opening” and “closing” of chromatin structure to allow for viral and cellular processes to occur. This chromatin remodeling occurs through two major mechanisms: covalent epigenetic modifications of N-terminal histone tails and ATP-dependent chromatin remodeling complexes (CRCs). HTLV-1 Tax has been shown by us and others to effectively regulate both steps. Here, we will discuss the effect of BAF and PBAF using a series of siRNA experiments for both basal and activated transcription. We observed that BAF complexes are regulated by phosphorylation of Baf 53 subunit (possibly by pTEF-b) and PBAF complexes substitute the negative inhibitory BAF complexes needed for activated transcription. We believe that Baf 53 activity is through closing of the chromatin structure at the transcription start site and that PBAF is able to aid in elongation by communicating with p300/PCAF and histone acetylated tails. Implications of these complexes in transcription for both viral and cellular genes will be discussed.

Authors’ Affiliations

School of Systems Biology, National Center for Biodefense & Infectious Diseases, George Mason University, Manassas, Virginia, USA
Department of Microbiology, Immunology, & Tropical Medicine, The George Washington University Medical Center, Washington, D.C., USA


© Guendel et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.